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httcense.Abstract Background: COPD and brochiectasis are characterized by ﬁxed airway obstruction and
chronic cough. The ﬁnding of bronchiectasis on HRCT scan in the patient with COPD may indicate
the presence of more advanced airway dysfunction, frequent exacerbation and bacterial coloniza-
tion.
Objective: The aim of this study to evaluate the incidence of bronchiectasis on high resolution
computed tomography (HRCT) scanning in patients with moderate and severe COPD, and to relate
this with the presence of lower airway bacterial colonization, exacerbation frequency, severity.
Patients and methods: This study was carried out on 69 patients diagnosed with COPD. All cases
were subjected to through history taking, lung function test, sputum culture, HRCT scan of the
chest to diagnose bronchiectasis, All the test were performed in a stable phase.
Results: 69 COPD patients, 32 patients had moderate COPD, 37 patients had severe COPD, 33
patients (47,8%) presented with brochiectasis, (31.3%) of the patients with moderate COPD and
62.2% of the patients with severe COPD with statistically signiﬁcant difference, the more severe
functional impairment (FEV1 6 50%) the greater prevalence of brochiectasis, also the greater bac-
terial colonization and more exacerbation were associated with the presence of brochiectasis.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
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Patients with chronic obstructive pulmonary disease (COPD)
are prone to exacerbation, which account for signiﬁcant mor-
bidity and mortality and are a key determinant of health re-
lated quality of life [1].
Bronchiectasis and COPD share many characteristics, from
both the physiopathologic [2,3] and clinical-functional view-
points [4,5]. Some authors have observed an association be-
tween the two reporting the presence of bronchiectasis in up
to 50% of patients with moderate to severe COPD [6,7]; this
suggests that there may be a causal relationship in which
COPD is a risk factor for bronchiectasis. There is considerableis. Production and hosting by Elsevier B.V.
07.001
Figure 2 Bar of the bacterial isolates found in the study.
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COPD exacerbations, which cannot be accounted for solely
on the basis of degrees of airway obstruction or disease sever-
ity. Mechanisms governing the natural history of COPD exac-
erbations remain poorly understood. Lower airway bacterial
colonization is a common clinical ﬁnding in COPD [8] and is
increasingly recognized as an independent stimulus to airway
inﬂammation [9]. We have shown that lower airway bacterial
colonization can modulate the character and frequency of
COPD exacerbations [10]. Patients with COPD and bronchiec-
tasis have greater bronchial inﬂammation, greater chronic col-
onization of bronchial mucosa by a potentially pathogenic
microorganism (PPM), and al longer duration of acute infec-
tious exacerbations. Due to the widespread and increasing
use of high resolution CT (HRCT) scanning in patients with
pulmonary symptoms, bronchiectasis is increasingly being rec-
ognized across the spectrum of patients with chronic cough
and dyspnea [11].
One study reported that 29% of patients with COPD who
developed an exacerbation in primary care were found to have
some bronchiectatic changes when evaluated by computed
tomography scanning [12]. In 2002, Barker described the over-
lapping and contrasting features between bronchiectasis and
COPD [13]. If there is truth in the hypothesis that patients with
both COPD and bacterial colonization by PPM have worse
prognosis, [14,15] the early identiﬁcation of patients with
COPD and bronchiectasis would be a signiﬁcant advance, as
it would provide opportunities to start early treatment (see
Figs. 1–4).
This study was designed to evaluate the incidence of bron-
chiectasis on high resolution computed tomography (HRCT)
scanning in patients with moderate and severe COPD, and
to relate this with the presence of lower airway bacterial colo-
nization, exacerbation frequency, severity.
Subject and methods
Study subjects
The study included 69 patients diagnosed with COPD, accord-
ing to international standard, COPD was deﬁned as a post
bronchodilator ration of FEV1/FVC < 70%, adjusted forFigure 1 Bar of the most signiﬁcant difference inage and height in patient with a smoking habit of >10 pack
years and b2 agonist reversibility on predicted FEV1 of
<15% and/or 200 ml. COPD was deﬁned as moderate if the
post bronchodilator FEV1 was 670% and severe if the post
bronchodilator FEV1 was 650% [16]. Patients with previously
diagnosed of bronchiectasis or other signiﬁcant respiratory dis-
ease were excluded. Subjects were recruited when stable. With-
out any evidence of an exacerbation for at least 6 weeks.
HRCT scan
High resolution CT was performed on a 16-slice helical CT
scanner (bright speed GE) with a pitch 0.98, 200–250 mA
and 120 kV. Plain scan of the chest was performed from the le-
vel of thoracic inlet to just below the inferior pole of the kidney
[17].
Axial Scans in both prone and supine positions were
performed;
1–1.5 mm collimation at 2 cm intervals in full inspiration.
Measure ﬁeld of view.
High spatial frequency reconstruction algorithm (can use
bone algorithm on GE machine).
Full inspiration.
Window:COPD cases with and without bronchiectasis.
Figure 3 Diffuse bronchiactic changes of the right lung.
Figure 4 (A & B) Localized are of bronchiectasis affecting left lower lung lobe.
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- Lung 1000 width, level 700.
1 s gantry rotation (depends on mAs selected).
Expiratory Views 3 postexpiratory views are routinely per-
formed at the level of the:
aortic arch,
at the tracheal carina, and
above the diaphragm.
These images are performed with 1–1.5 mm collimation at
end expiration following a forced vital.
Images should be photographed using a window level of
700 HU, and a width of 1000–1500 HU. The generated axial
images were then transferred to second workstation (extended
brilliance work space BWS 3.5) for display in various 2D and
3D techniques [18].
Sputum samples: Sputum samples at home, using the most
sterile technique possible, and they were asked to deposit these
samples in the hospital laboratory, always within a maximum
of 3 h after collection. Sputum samples were accepted if they
contained <25 squamous epithelial cells per low powered
ﬁeld. The samples were separated from saliva, gram stained,
and homogenized. Diluted secretions were plated on blood,
chocolate, and MeConkey and Sabouraud agar. Sputumcultures were expressed as colony forming units (CFUs) per
milliliter. For the purposes of this study, a cutoff point of
P103 was deﬁned as signiﬁcant for the identiﬁcation of abnor-
mal positive culture results for PPM, according to published
methods. [19–21].
Statistical analysis
The data collected were statistically analyzed using statistical
package for social sciences (SPSS/version 16) software.
(Inc., Chicago, USA). Parametric data was expressed as
mean ± SD, and non parametric data was expressed as num-
ber and percentage of the total. Student t-test for quantitative
independent variables was done for analysis of difference be-
tween two groups. Chi-square test of signiﬁcance was used in
order to compare proportion between tow categorical vari-
ables. In all tests, p-value <0.05 is considered signiﬁcant,
p-value <0.01 is considered highly signiﬁcant.
Results
69 Patients with moderate to severe COPD were analyzed, 32
patients had moderate COPD (46.3%), mean age 59.4 years;
93.8% men, 37 patients (53.6) had severe COPD, mean age
60.4 years; of the cases.94.6% men. Table 1 presents the demo-
graphics of the cases.
Table 1 Demographics & data of the cases.
Moderate Severe
n= 32 n= 37
Age 59.47 ± 6.43 60.43 ± 6.74
Sex female 2 (6.3%) 2 (5.4%)
Male 30 (93.8%) 35 (94.6%)
FEV1 55.94 ± 3.68 45.43 ± 4.48
FEV1/FVC 64.09 ± 3.16 51.38 ± 8.70
Data are represented as Mean ± SD.
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present in 31.3% only in patients with moderate COPD, while
62.2% in patients with severe COPD with statistically signiﬁ-
cant difference.
Haemophilus inﬂuenza is the most frequent pathogen fol-
lowed by Streptococcus pneumonia while Pseudomonas aeru-
ginosa is the most frequent pathogen in COPD cases with
Bronchiectasis.
Mild thickening is less than the diameter of the adjacent
vessel, moderate, similar to the diameter of the adjacent vessel,
severe, greater than the diameter of the adjacent vessel (see Ta-
bles 2–5).
Axial HRCT of both lungs show widespread thin-walled,
air-ﬁlled cysts, Interstitial and peripronchial thickening.
Axial and coronal images show peribronchial thickening,
clyndrical shape bronchiectasis, and tree-in-bud appearance
of peripheral bronchi.
Discussion
A number of previous studies have examined relationships be-
tween structural changes seen on HRCT scanning and func-
tional or physiological parameters in COPD [22,23]. It is not
known, however, whether morphologic changes in the airways
or lung parenchyma in usual COPD in the stable state can re-
lated to the number or severity of exacerbations experienced
by patients, or to levels of airway inﬂammation. Recurrent
COPD exacerbations are associated with a heightened airway
inﬂammatory burden, and with the presence of lower airway
bacterial colonization [24,25], which in turn has been shown
to be an independent stimulus to airway inﬂammation in
COPD [26,27]. In addition, we have found that lower airway
bacterial colonization in the stable state is associated with in-
creased symptom counts and sputum purulence at exacerba-
tion [24].
The present study examined a well characterized group of
hospital outpatients with moderate to severe COPD. HRCT
scans of the chest were performed on patients in the stable
state and the extent of bronchiectasis was quantiﬁed.
HRCT is now accepted as the imaging modality of choice
for the evaluation of bronchiectasis [28].Table 2 Presents the incidence of bronchiectasis.
Moderate COPD (n= 32)
Bronchiectasis 10(31.3%)
Signiﬁcant when p< 0.05.The prevalence of bronchiectasis in patients with moderate
to severe COPD in this study was 47.8%; it was primarily of
cylindric type, mainly localized in the lower lobes very similar
to that found by Martinez Garcia et al. [29], they found that
57.6% of patients with moderate to severe COPD have bron-
chiectasis on HRCT.
Other recent studies in patients with COPD with all GOLD
(Global Initiative for Chronic Obstructive Lung Disease)
stages of disease showed bronchiectasis rates of 27% in 75
UK patients [30], and 45 in 2,164 subjects in the multinational
Evaluation of COPD longitudinally to Identify Predictive Sur-
rogate Endpoints (ECLIPSE) cohort [31].
An important ﬁnding in this study was the relationship
between the detection of radiologic bronchiectasis on HRCT
and more severe COPD exacerbations, as assessed by time
to symptom recovery. We have previously shown that exac-
erbation severity in COPD can be related to this parameter
[32].
Incidence of bronchiectasis in moderate COPD was 31.3%
while 62.2% in severe COPD. Similar results was found by pa-
tel et al. [6] also Martinez-Garcia et al. [29] who concluded in
patients with both COPD and severe functional impairment
(FEV1 6 50%) presented a greater prevalence of bronchiecta-
sis (>70%).
The extent of lower lobe bronchiectasis was also related to
the presence of lower airway bacterial colonization which pres-
ent in 40.5% of cases; 51.5% in severe COPD and 30.5% in
moderate COPD.
The presence of bacteria in the lower airway in COPD im-
plies a breach of host defense mechanisms, which fuels a vi-
cious cycle of structural damage, loss of epithelial cell
integrity [33], impaired mucociliary clearance [34], and mucus
hypersecretion [35]. This results in further mucosal injury
and inﬂammation, which could thereby provide the mecha-
nism for longer and more severe COPD exacerbations.
These results concur once again with those reported by pa-
tel et al. [6] who observed in 54 patients with moderate to se-
vere COPD, that greater bronchial colonization by PPM was
associated with presence of bronchiectasis.
The most frequently isolated microorganism was H.inﬂu-
enza, Also our results indicate that the presence of p. aerugin-
osa could potentially be a marker for bronchiectasis in patients
with moderate to severe COPD, similar results was found by
Martinez-Garcia et al. [29].
COPD could therefore be a risk factor for bronchiectasis
although longitudinal studies are needed to demonstrate this
hypothesis. There is at least one hospital admission for acute
exacerbation of COPD in the year prior to inclusion in the
study considered a marker of severe exacerbation Patel et al.
[6] observed that even though the number of exacerbations
was not related to bronchiectasis in their study, patients with
bronchiectasis did experience longer exacerbations. The discor-
dance between these studies can be explained by the fact that,
in our study, only data from exacerbations that requiredSevere COPD (n= 37) p-value
23(62.2%) 0.010
Table 3 Characteristics of COPD patients with and without bronchiectasis.
COPD without bronchiectasis COPD with bronchiectasis p value
No 36 33
Sex female 32 (88.9%) 33 (100%)
Male 4 (11.1%) 0 (0%)
Age 56.50 ± 5.56 63.79 ± 5.41 <0.001
Pack-y smoked 34.72 ± 9.10 48.48 ± 7.01 <0.001
FEV1 53.72 ± 5.28 46.58 ± 6.07 <0.001
FEV1/FVC 61.94 ± 4.20 52.18 ± 10.53 <0.001
Daily dyspnea 6 (18.2%) 26 (78.8%) <0.001
Usual sputum aspect
Mucoid 31 (86.1%) 0 (0%) <0.001
Muco purulent 5 (13.9%) 19 (57.6%)
Purulent 0 (0%) 14 (42.4%)
Positive sputum culture 11 (30.5%) 17 (51.5%) 0.001
Acute antibiotics treatment 5 (13.9%) 24 (72.7%) <0.001
Admission in previous year 8 (22.2%) 19 (57.5%) <0.001
Signiﬁcant when p< 0.05.
Table 4 Bacterial isolate found during the study.
COPD without
bronchiectasis
COPD with
bronchiectasis
Haemophilus inﬂuenza 5(45.4%) 5(29.4%)
Streptococcus pneumoniae 5(45.5%) 3(17.6%)
Pseudomonas aeruginosa 1(9%) 6(35.2%)
Klebsiella pneumoniae 0(0%) 3(17.6%)
Table 5 Bronchiectasis characteristics in CT scan in COPD
patients with bronchiectasis.
Characteristics No (%)
No of patients 33 (47.8%)
Type
Cylindric 27 (81.8%)
Saccular 7 (21.2%)
Location
Lower lobe 22 (66.6%)
Upper lobe 5 (15.1%)
Bilaterality
Bilateral 24 (72.8%)
Unilateral 9 (27.3%)
Thickening of bronchial wall
Mild 10 (50%)
Moderate 6 (30%)
Severe 4 (20%)
Other ﬁndings
Pneumonia 4 (40%)
Old TB 2 (20%)
Adenoparly 2 (20%)
Atelectasis 2 (20%)
Data are presented as No (%).
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more severe, whereas the study by Patel and colleagues [6] col-
lected information from a ‘‘ symptom diary’’ covering the full
severity range of exacerbations.Also incidence of chronic expectoration or daily dyspnea or
periods with prescribed antibiotics is increased in COPD pa-
tients with bronchiectasis with signiﬁcant difference than the
COPD patients without bronchiectasis so there variables are
characteristic of bronchiectasis [11,36,37].
According to our results, there is a wide range of possibili-
ties from the patients with severe COPD, with bacterial coloni-
zation or at least on hospital admission in the previous year,
who would have a high probability of presenting bronchiecta-
sis, to the patients with moderate COPD. Our results suggest
the use of HRCT scan to role out the presence of bronchiecta-
sis in those patients who have severe airﬂow obstruction.
Conclusion
According to our results from the patients with moderate to se-
vere COPD, there is high prevalence of radiologic bronchiecta-
sis in there groups of patients with severe airﬂow obstruction,
bacterial colonization in a sputum sample, and the need for at
least on hospital admission in the previous year.
So HRCT scanning may be useful for detection of bronchi-
ectasis in these group of patients.
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